Showing results (31-40 of 158) with videos related to
Sort By:
Pageof 16
Nature Reviews. Nephrology|July 20, 2021
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney functionEoin Brennan, Phillip Kantharidis, Mark E Cooper, et al.Atherosclerosis|October 6, 2024
The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic alliesElena Giardini, Dean Moore, Denise Sadlier, et al.Accountability in Research|November 14, 2023
Teaching research integrity as discussed in research integrity codes: A systematic literature reviewDaniel Crean, Bert Gordijn, Alan J KearnsScience and Engineering Ethics|July 23, 2024
Impact and Assessment of Research Integrity Teaching: A Systematic Literature ReviewDaniel Crean, Bert Gordijn, Alan J KearnsThe American Journal of Pathology|August 30, 2005
Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cellsKaren Rodgers, Blaithin McMahon, Derick Mitchell, et al.Trends in Cell Biology|March 2, 2010
Extracellular BMP-antagonist regulation in development and disease: tied up in knotsDavid W Walsh, Catherine Godson, Derek P Brazil, et al.Genes|April 8, 2014
The genetics of diabetic nephropathyEoin Brennan, Caitríona McEvoy, Denise Sadlier, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Lipoxin A4 redistributes myosin IIA and Cdc42 in macrophages: implications for phagocytosis of apoptotic leukocytesKeira Reville, John K Crean, Sharon Vivers, et al.Experimental Nephrology|April 9, 2002
Gene responses to hyperglycaemiaDavid W P Lappin, Peter Doran, Catherine Godson, et al.European Journal of Medicinal Chemistry|January 24, 2021
Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potentialMonika Maciuszek, Antonino Cacace, Eoin Brennan, et al.Pageof 16